期刊
FRONTIERS IN AGING NEUROSCIENCE
卷 7, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2015.00020
关键词
retinoic acid; nanoparticles; neuroprotection; dopaminergic neurons; Parkinson's disease
资金
- FCT Portugal
- FEDER [PTDC/SAU-NEU/104415/2008, EXPL/BIM-MED/0822/2013]
- L'Oreal-UNESCO Portugal for Women in Science - FEDER (QREN) [CENTRO-07-5T24-FEDER-002008, COMPETE: PEst-C/SAU/UI0709/2011]
- Portuguese Foundation for Science and Technology FCT [SFRH/BPD/69643/2010]
- Fundação para a Ciência e a Tecnologia [EXPL/BIM-MED/0822/2013, SFRH/BPD/69643/2010] Funding Source: FCT
Retinoic acid (RA) plays an important role in the commitment, maturation and survival of neural cells. Recently, RA was pointed as a therapeutic option for some neurodegenerative diseases, including Parkinson's disease (PD). The administration of RA has been defying, and in this sense we have previously developed novel RA-loaded polymeric nanoparticles (RA-NPs) that ensure the efficient intracellular transport and controlled release of RA. Herein, we show that nanoformulation as an efficient neuroprotective effect on dopaminergic (DA) neurons in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mouse model for PD. The results showed that the RA-NPs administration induced a significant reduction of DA neuron loss in the substantia nigra (SN) as well as their neuronal fiber/axonal innervations in the striatum. Furthermore, we observed an increase in the expression levels of the transcription factors Pitx3 and Nurr1 induced by RA-NPs, showing its supportive effect on the development and functional maintenance of DA neurons in PD. This is the first study showing that RA-NPs can be an innovative strategy to halt the progression of PD pathogenesis, suggesting that this nanoformulation could be of particular interest for the development of new approaches for PD therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据